Molecules 2012, 17(5), 4972-4985; doi:10.3390/molecules17054972
Article

Synthesis and Biological Evaluation of New Ligustrazine Derivatives as Anti-Tumor Agents

Penglong Wang 1 , Gaimei She 1 , Yanan Yang 2 , Qiang Li 1 , Honggui Zhang 1 , Jie Liu 1 , Yinqiu Cao 1 , Xin Xu 1  and Haimin Lei 1,* email
1 School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China 2 Institute of Materia Medica, Chinese Academy of Medical Sciences Peking Union Medical College, Beijing 100050, China
* Author to whom correspondence should be addressed.
Received: 19 March 2012; in revised form: 18 April 2012 / Accepted: 20 April 2012 / Published: 30 April 2012
PDF Full-text Download PDF Full-Text [403 KB, uploaded 30 April 2012 09:21 CEST]
Abstract: To discover new anti-cancer agents with multi-effect and low toxicity, a series of ligustrazine derivatives were synthesized using several effective anti-tumor ingredients of Shiquandabu Wan as starting materials. Our idea was enlightened by the “combination principle” in drug discovery. The ligustrazine derivatives’ anti-tumor activities were evaluated on the HCT-8, Bel-7402, BGC-823, A-549 and A2780 human cancer cell lines. In addition the angiogenesis activities were valued by the chick chorioallantoic membrane (CAM) assay. 1,7-bis(4-(3,5,6-Trimethylpyrazin-2-yl)-3-methoxyphenyl)-1,6-heptadiene-3,5-dione (4) and 3 α,12 α-dihydroxy-5β-dholanic acid-3,5,6-trimethylpyrazin-2-methyl ester (5) not only displayed antiproliferative activities on these cancer cells, but also dramatically suppressed normal angiogenesis in CAM. The LD50 value of the compound 5 exceeded 3.0 g/kg by oral administration in mice.
Keywords: angiogenesis; anti-tumor; combination principles; ligustrazine derivatives; low toxicity

Supplementary Files

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Wang, P.; She, G.; Yang, Y.; Li, Q.; Zhang, H.; Liu, J.; Cao, Y.; Xu, X.; Lei, H. Synthesis and Biological Evaluation of New Ligustrazine Derivatives as Anti-Tumor Agents. Molecules 2012, 17, 4972-4985.

AMA Style

Wang P, She G, Yang Y, Li Q, Zhang H, Liu J, Cao Y, Xu X, Lei H. Synthesis and Biological Evaluation of New Ligustrazine Derivatives as Anti-Tumor Agents. Molecules. 2012; 17(5):4972-4985.

Chicago/Turabian Style

Wang, Penglong; She, Gaimei; Yang, Yanan; Li, Qiang; Zhang, Honggui; Liu, Jie; Cao, Yinqiu; Xu, Xin; Lei, Haimin. 2012. "Synthesis and Biological Evaluation of New Ligustrazine Derivatives as Anti-Tumor Agents." Molecules 17, no. 5: 4972-4985.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert